After a wave of supply deals, British drugmaker AstraZeneca is working to secure enough capacity to meet what could be a 3 billion-dose demand for its COVID-19 vaccine front-runner. To hit that lofty goal, AstraZeneca needs partners—and the company is …
See Original Article

As its ride-sharing business continues to struggle during the COVID-19 pandemic, Uber announced that it will begin to require some riders to take selfies to prove they are wearing masks. The company already requires drivers and delivery workers to take …
See Original Article

After being bounced by Bristol Myers after its Celgene takeover, Jounce is courting again, this time an early romance with Gilead Sciences. BMS made the final cut to a longstanding immuno-oncology pact with Jounce back in June, coming as it swung the ax …
See Original Article

WASHINGTON (Reuters) – U.S. manufacturing activity accelerated to a more than 1-1/2-year high in August amid a surge in new orders, but employment continued to lag, supporting views that the labor market recovery was losing momentum. The Institute for …
See Original Article

FDA has approved Medtronic’s MiniMed 770G hybrid closed loop diabetes management system for use in children between the ages of 2 and 6 years old with Type 1 diabetes. It’s the first legally marketed device to automatically adjust insulin delivery based …
See Original Article